On February 25, Zomedica Corp. (ZOM) provided its Q4 and fiscal 2021 revenue and gross margin update. Consequently, the stock rebounded in the after-hours on
Zomedica Corp. (ZOM) is veterinary wellness and health-based company. It offers diagnostics and treatments for pets by fixing their unmet medical needs. The company’s product
In the current market, Zomedica Corp. (ZOM) stock plummeted by 0.77% to the price of $0.84 at the time of writing. ZOM stock closed its
Zomedica Corp (ZOM) stock recently traded at $1.33 which is an 8.90% downward movement. The ZOM stock previously closed at $1.46. ZOM stock also plunged
The global pandemic has affected many high price stocks and with much uncertainty, we have certain cheap stocks to watch for. Last year has been
Zomedica Corp.’s (NYSE: ZOM) stock has soared by 8.73% to the current value of $2.49. In the after-hours market, the ZOM stock rose by %10.84.
Stock markets recovered strongly from the price dip at the end of January last week. In New York, the indices even managed to set new
Bionano Genomics Inc. (BNGO) stock soared 46.62% to $1.95 in the pre-market trading after reporting that Praxis Genomics, LLC received accreditation from the College of
Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -5.88% at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund. ATIF Holdings Limited (ATIF) stock
Avinger Inc. (AVGR) stock plunged -7.38% to $0.4445 in the pre-market trading. The most recent rating by Ladenburg Thalmann, on March 09, 2018, is a
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.